4.6 Article

Association of relative telomere length with cardiovascular disease in a large chronic kidney disease cohort: The GCKD study

Journal

ATHEROSCLEROSIS
Volume 242, Issue 2, Pages 529-534

Publisher

ELSEVIER IRELAND LTD
DOI: 10.1016/j.atherosclerosis.2015.08.020

Keywords

Telomere length; Cardiovascular disease; Chronic kidney disease; High-risk population

Funding

  1. German Ministry of Education and Research (BMBF) [01ER 0804, 01ER 0818, 01ER 0819, 01ER 0820, 01ER 0821]
  2. KfH Foundation for Preventive Medicine

Ask authors/readers for more resources

Background: Chronic kidney disease (CKD) affects 10e15% of the general population and affected individuals are at an increased risk for cardiovascular disease (CVD). Since telomere length is considered to be involved in biological aging, we tested whether relative telomere length (RTL) might be a marker for these two diseases. Methods: The German Chronic Kidney Disease (GCKD) study is an ongoing prospective cohort study including patients with CKD of moderate severity. RTL was measured by qPCR in 4955 out of 5217 GCKD patients at baseline. Results: RTL was distributed in the cohort with a mean +/- SD of 0.95 +/- 0.19. CVD was present in 1266 patients. Each decrease of RTL by 0.1 unit was associated with a higher probability for prevalent CVD: OR = 1.06, 95% CI 1.02-1.11, p = 0.007 (adjusted for age, sex, eGFR, BMI, ln-CRP, smoking, hypertension, diabetes, and lipids). Similar findings were observed for history of specific CVD entities, such as coronary artery disease (OR = 1.05, p = 0.025), myocardial infarction (OR = 1.08, p = 0.013) and percutaneous transluminal coronary angioplasty (OR = 1.06, p = 0.032). The strongest associations were found for interventions at the carotid arteries (OR = 1.25, p = 0.001) as well as aortic aneurysms (OR = 1.22, p = 0.001). Conclusions: In the presence of CKD there is a significant association between shorter RTL and CVD manifestations. RTL appears to be a marker reflecting changes in homeostasis associated with CKD that may contribute to the excess CVD risk. (C) 2015 Elsevier Ireland Ltd. All rights reserved.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Infectious Diseases

SARS-CoV-2 infection in chronic kidney disease patients with pre-existing dialysis: description across different pandemic intervals and effect on disease course (mortality)

Lisa Pilgram, Lukas Eberwein, Bjoern-Erik O. Jensen, Carolin E. M. Jakob, Felix C. Koehler, Martin Hower, Jan T. Kielstein, Melanie Stecher, Bernd Hohenstein, Fabian Prasser, Timm Westhoff, Susana M. Nunes de Miranda, Maria J. G. T. Vehreschild, Julia Lanznaster, Sebastian Dolff

Summary: This multicentre cohort study aimed to evaluate the situation of CKD5D patients during the COVID-19 pandemic and investigate the association between dialysis dependency and mortality. The results showed that dialysis dependency was not related to mortality, but the mortality rate of CKD patients was high.

INFECTION (2023)

Article Transplantation

Uromodulin and its association with urinary metabolites: the German Chronic Kidney Disease Study

Helena Baechle, Peggy Sekula, Pascal Schlosser, Inga Steinbrenner, Yurong Cheng, Fruzsina Kotsis, Heike Meiselbach, Helena Stockmann, Sebastian Schoenherr, Kai-Uwe Eckardt, Olivier Devuyst, Juergen Scherberich, Anna Koettgen, Ulla T. Schultheiss

Summary: This study aimed to explore metabolites associated with uromodulin concentrations and evaluate their association with the progression of chronic kidney disease (CKD) and adverse kidney events. The study found that higher levels of urinary and serum uromodulin were associated with a lower risk of adverse kidney events, suggesting a potential protective role of functional nephrons in CKD outcomes.

NEPHROLOGY DIALYSIS TRANSPLANTATION (2023)

Article Transplantation

Association of osteopontin with kidney function and kidney failure in chronic kidney disease patients: the GCKD study

Inga Steinbrenner, Peggy Sekula, Fruzsina Kotsis, Maja von Cube, Yurong Cheng, Jennifer Nadal, Matthias Schmid, Markus P. Schneider, Vera Krane, Matthias Nauck, Kai-Uwe Eckardt, Ulla T. Schultheiss

Summary: In this study, higher levels of OPN were found to be associated with worsening kidney function markers and an increased risk of adverse outcomes in CKD patients. A larger proportion of KF events could be attributed to higher OPN levels.

NEPHROLOGY DIALYSIS TRANSPLANTATION (2023)

Article Cardiac & Cardiovascular Systems

Including measures of chronic kidney disease to improve cardiovascular risk prediction by SCORE2 and SCORE2-OP

Kunihiro Matsushita, Stephen Kaptoge, Steven H. J. Hageman, Yingying Sang, Shoshana H. Ballew, Morgan E. Grams, Aditya Surapaneni, Luanluan Sun, Johan Arnlov, Milica Bozic, Hermann Brenner, Nigel J. Brunskill, Alex R. Chang, Rajkumar Chinnadurai, Massimo Cirillo, Adolfo Correa, Natalie Ebert, Kai Uwe Eckardt, Ron T. Gansevoort, Orlando Gutierrez, Farzad Hadaegh, Jiang He, Shih Jen Hwang, Tazeen H. Jafar, Simerjot K. Jassal, Takamasa Kayama, Csaba P. Kovesdy, Gijs W. Landman, Andrew S. Levey, Donald M. Lloyd-Jones, Rupert W. Major, Katsuyuki Miura, Paul Muntner, Girish N. Nadkarni, Christoph Nowak, Takayoshi Ohkubo, Michelle J. Pena, Kevan R. Polkinghorne, Toshimi Sairenchi, Elke Schaeffner, Markus P. Schneider, Varda Shalev, Michael G. Shlipak, Marit D. Solbu, Nikita Stempniewicz, James Tollitt, Jose M. Valdivielso, Joep van der Leeuw, Angela Yee Moon Wang, Chi Pang Wen, Mark Woodward, Kazumasa Yamagishi, Hiroshi Yatsuya, Luxia Zhang, Jannick A. N. Dorresteijn, Emanuele Di Angelantonio, Frank L. J. Visseren, Lisa Pennells, Josef Coresh

Summary: This study developed an "Add-on" method to incorporate chronic kidney disease (CKD) measures into cardiovascular disease (CVD) risk prediction algorithms, which improved the predictive accuracy. This approach will assist clinicians and patients in more precise risk assessment and personalized preventive therapies for CKD.

EUROPEAN JOURNAL OF PREVENTIVE CARDIOLOGY (2023)

Article Clinical Neurology

Mitochondrial DNA heteroplasmy distinguishes disease manifestation in PINK1/PRKN-linked Parkinson's disease

Joanne Trinh, Andrew A. Hicks, Inke R. Koenig, Sylvie Delcambre, Theresa Lueth, Susen Schaake, Kobi Wasner, Jenny Ghelfi, Max Borsche, Carles Vilarino-Gueell, Faycel Hentati, Elisabeth L. Germer, Peter Bauer, Masashi Takanashi, Vladimir Kostic, Anthony E. Lang, Norbert Brueggemann, Peter P. Pramstaller, Irene Pichler, Alex Rajput, Nobutaka Hattori, Matthew J. Farrer, Katja Lohmann, Hansi Weissensteiner, Patrick May, Christine Klein, Anne Gruenewald

Summary: Trinh et al. found that PINK1/PRKN mutations increase the risk of mitochondrial DNA variant accumulation in a dose- and disease-dependent manner. Monoallelic mutation carriers can be distinguished by the level of heteroplasmic mtDNA variants. Biallelic mutations in PINK1/PRKN lead to recessive Parkinson's disease.

BRAIN (2023)

Article Medical Laboratory Technology

Development of an LC-MRM-MS-Based Candidate Reference Measurement Procedure for Standardization of Serum Apolipoprotein (a) Tests

L. Renee Ruhaak, Fred P. H. T. M. Romijn, Ilijana Begcevic Brkovic, Zsusanna Kuklenyik, Julia Dittrich, Uta Ceglarek, Andrew N. Hoofnagle, Harald Althaus, Eduardo Angles-Cano, Stefan Coassin, Vincent Delatour, Liesbet Deprez, Ioannis Dikaios, Gerhard M. Kostner, Florian Kronenberg, Alicia Lyle, Urban Prinzing, Hubert W. Vesper, Christa M. Cobbaert, Int Federation Clinical Chem Lab Med Working Grp Apolipoproteins Mass Spect

Summary: In order to ensure the accuracy and reliability of medical results from in vitro diagnostic and in-house tests, a higher order reference measurement system traceable to endorsed reference measurement procedures and reference materials is needed. A candidate reference measurement procedure for serum apolipoprotein(a) [apo(a)] based on mass spectrometry was developed and provisionally validated. The method demonstrated accurate quantitation of serum apo(a) and fulfilled predefined analytical performance specifications.

CLINICAL CHEMISTRY (2023)

Article Cardiac & Cardiovascular Systems

Frequent questions and responses on the 2022 lipoprotein(a) consensus statement of the European Atherosclerosis Society

Florian Kronenberg, Samia Mora, Erik S. G. Stroes, Brian A. Ference, Benoit J. Arsenault, Lars Berglund, Marc R. Dweck, Marlys L. Koschinsky, Gilles Lambert, Francois Mach, Catherine J. McNeal, Patrick M. Moriarty, Pradeep Natarajan, Borge G. Nordestgaard, Klaus G. Parhofer, Salim S. Virani, Arnold von Eckardstein, Gerald F. Watts, Jane K. Stock, Kausik K. Ray, Lale S. Tokgozoglu, Alberico L. Catapano

Summary: In 2022, the European Atherosclerosis Society (EAS) released a new consensus statement on the relationship between lipoprotein(a) [Lp(a)] and atherosclerotic cardiovascular disease (ASCVD) and aortic stenosis. This statement highlights the importance of understanding Lp(a) concentration and its impact on lifetime risk for ASCVD. It also provides practical advice on using Lp(a) concentration to manage risk factors, despite the lack of currently available targeted therapies to lower Lp(a).

ATHEROSCLEROSIS (2023)

Article Nutrition & Dietetics

Differential Prognostic Utility of Adiposity Measures in Chronic Kidney Disease

Vladimir Cejka, Stefan Stoerk, Jennifer Nadal, Matthias Schmid, Claudia Sommerer, Thomas Sitter, Heike Meiselbach, Martin Busch, Markus P. Schneider, Turgay Saritas, Ulla T. Schultheiss, Fruzsina Kotsis, Christoph Wanner, Kai-Uwe Eckardt, Vera Krane

Summary: This study found that neck circumference and waist circumference were associated with increased risk of all-cause death in patients with chronic kidney disease, especially in women. However, body mass index was not associated with any of the analyzed outcomes.

JOURNAL OF RENAL NUTRITION (2023)

Article Biochemistry & Molecular Biology

Haplogrep 3-an interactive haplogroup classification and analysis platform

Sebastian Schoenherr, Hansi Weissensteiner, Florian Kronenberg, Lukas Forer

Summary: This paper presents a major upgrade to the Haplogrep software, including added features such as haplogroup summary statistics and variant annotations from various genome databases, improved algorithms for large-scale data, and a new web framework. These improvements allow researchers to classify and investigate thousands of samples more conveniently.

NUCLEIC ACIDS RESEARCH (2023)

Article Pharmacology & Pharmacy

Daring to dream: Targeting lipoprotein(a) as a causal and risk-enhancing factor

Marlys L. Koschinsky, Erik S. G. Stroes, Florian Kronenberg

Summary: This review focuses on the causal association between Lipoprotein(a) (Lp(a)) and cardiovascular outcomes, the mechanisms by which elevated Lp(a) contributes to cardiovascular diseases, the metabolic insights on the production and clearance of Lp(a), and the current and future therapeutic approaches to lower Lp(a) concentrations.

PHARMACOLOGICAL RESEARCH (2023)

Review Medicine, General & Internal

Magnetic Resonance Imaging in Clinical Trials of Diabetic Kidney Disease

Iris Friedli, Seema Baid-Agrawal, Robert Unwin, Arvid Morell, Lars Johansson, Paul D. Hockings

Summary: Diabetic kidney disease (DKD) is a serious healthcare problem worldwide, and non-invasive biomarkers are needed for early diagnosis and disease monitoring. Magnetic resonance imaging (MRI) may provide a solution for DKD diagnosis and assessment.

JOURNAL OF CLINICAL MEDICINE (2023)

Article Medicine, General & Internal

Long and Short-Term Effects of Hypothermic Machine Perfusion vs. Cold Storage on Transplanted Kidneys from Expanded Criteria Donors-A Matched Comparison Study

Matthias Axelsson, Per Lindner, Nils-Gunnar Pehrsson, Seema Baid-Agrawal

Summary: This retrospective observational study evaluated the effect of hypothermic machine perfusion (HMP) on delayed graft function (DGF) and graft survival in kidneys from expanded criteria donors (ECD). The results showed that HMP can reduce DGF rates but does not have a significant impact on graft survival.

JOURNAL OF CLINICAL MEDICINE (2023)

Article Biochemistry & Molecular Biology

Systemic Evidence for Mitochondrial Dysfunction in Age-Related Macular Degeneration as Revealed by mtDNA Copy Number Measurements in Peripheral Blood

Adriana Koller, Claudia Lamina, Caroline Brandl, Martina E. Zimmermann, Klaus J. Stark, Hansi Weissensteiner, Reinhard Wuerzner, Iris M. Heid, Florian Kronenberg, Jay Stewart

Summary: This study suggests that mtDNA copy number in blood may serve as a more accessible biomarker for age-related macular degeneration (AMD) than mtDNA copy number in the retina, providing new insights into the relationship between mtDNA-CN and AMD.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2023)

No Data Available